EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Discrimination of the Cardiometabolic Index for Prevalent Metabolic Syndrome in Postmenopausal Women With Severe Obesity: A Cross‐Sectional Study

Daniel de Luis iD, Olatz Izaola, Juan José Lopez Gomez, Daniel Rico, David Primo

Health Science Reports · 2026-11 · 9 (11)

DOI: 10.1002/hsr2.73503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 10.11.2026. Verfasst von Daniel de Luis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid Valladolid Spain. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The cardiometabolic index (CMI), combining waist‐to‐height ratio and the triglyceride‐to‐HDL cholesterol ratio, shares components with the diagnostic definition of metabolic syndrome (MetS). Its apparent discrimination therefore requires cautious interpretation.

Aim

To assess the association of CMI with prevalent MetS and describe its diagnostic discrimination alongside HOMA‐IR in postmenopausal women with severe obesity.

Methods

In this cross‐sectional study, anthropometric measures, blood pressure, fasting biochemical variables and MetS status were assessed concurrently in 499 postmenopausal women referred for evaluation of severe obesity (BMI > 35 kg/m 2 ). CMI = [triglycerides (mmol/L)/HDL cholesterol (mmol/L)] × [waist circumference/height], with both lengths expressed in the same unit. ROC analysis and the Youden index were used to describe discrimination and select cut‐offs.

Results

MetS was present in 300 women (60.1%). The reported association above versus below the median CMI of 0.74 was OR 2.65 (95% CI 1.99–3.53); its adjustment status and source analysis require verification. The reported AUCs were 0.76 (95% CI 0.71–0.80) for CMI and 0.70 (95% CI 0.66–0.81) for HOMA‐IR. At the reported cut‐offs of 0.84 and 2.64, respectively, sensitivities were 85.6% and 64.9%, and specificities 72.5% and 69.7%.

Conclusions

CMI was associated with prevalent MetS in this selected cross‐sectional sample. Component overlap with the MetS definition may affect apparent discrimination.

Schlagwörter

Stichwörter der Autor:innen

cardiometabolic indexhomeostatic model assessmentmetabolic syndromeobesitypostmenopausal

Autor:innen und Institutionen

  • Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid Valladolid Spain.
  • Valladolid Health Research Institute (IBioVALL) Valladolid Spain.
  • Centro de Investigación de Endocrinología y Nutrición Fac Medicina Universidad de Valladolid Valladolid Spain.
  • Centro de Investigación Biomedica en Red (CIBEROBN) de la Obesidad y Nutrición. Instituto de Salud Carlos III Madrid Spain.

ORCID-Profile: Daniel de Luis

Zitieren

APA

de Luis, D., Izaola, O., Gomez, J. J. L., Rico, D., & Primo, D. (2026). Diagnostic Discrimination of the Cardiometabolic Index for Prevalent Metabolic Syndrome in Postmenopausal Women With Severe Obesity: A Cross‐Sectional Study. Health Science Reports, 9(11). https://doi.org/10.1002/hsr2.73503

Vancouver

de Luis D, Izaola O, Gomez JJL, Rico D, Primo D. Diagnostic Discrimination of the Cardiometabolic Index for Prevalent Metabolic Syndrome in Postmenopausal Women With Severe Obesity: A Cross‐Sectional Study. Health Science Reports. 2026;9(11). doi:10.1002/hsr2.73503

BibTeX
@article{deLuis2026,
  author = {de Luis, Daniel and Izaola, Olatz and Gomez, Juan José Lopez and Rico, Daniel and Primo, David},
  title = {Diagnostic Discrimination of the Cardiometabolic Index for Prevalent Metabolic Syndrome in Postmenopausal Women With Severe Obesity: A Cross‐Sectional Study},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {11},
  doi = {10.1002/hsr2.73503}
}
Kostenlos starten →